223 related articles for article (PubMed ID: 32795367)
1. Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya.
Chebore W; Zhou Z; Westercamp N; Otieno K; Shi YP; Sergent SB; Rondini KA; Svigel SS; Guyah B; Udhayakumar V; Halsey ES; Samuels AM; Kariuki S
Malar J; 2020 Aug; 19(1):291. PubMed ID: 32795367
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum cases and molecular surveillance of drug resistance genes in Western Myanmar.
Wu Y; Soe MT; Aung PL; Zhao L; Zeng W; Menezes L; Yang Z; Kyaw MP; Cui L
Malar J; 2020 Aug; 19(1):304. PubMed ID: 32854686
[TBL] [Abstract][Full Text] [Related]
3. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria.
Nguetse CN; Adegnika AA; Agbenyega T; Ogutu BR; Krishna S; Kremsner PG; Velavan TP
Malar J; 2017 May; 16(1):217. PubMed ID: 28535801
[TBL] [Abstract][Full Text] [Related]
5. Molecular surveillance of anti-malarial resistance pfcrt, pfmdr1, and pfk13 polymorphisms in African Plasmodium falciparum imported parasites to Wuhan, China.
Cheng W; Song X; Tan H; Wu K; Li J
Malar J; 2021 May; 20(1):209. PubMed ID: 33933099
[TBL] [Abstract][Full Text] [Related]
6. Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya.
Zhou Z; Gimnig JE; Sergent SB; Liu Y; Abong'o B; Otieno K; Chebore W; Shah MP; Williamson J; Ter Kuile FO; Hamel MJ; Kariuki S; Desai M; Samuels AM; Walker ED; Shi YP
Malar J; 2022 Sep; 21(1):265. PubMed ID: 36100912
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.
Ishengoma DS; Mandara CI; Francis F; Talundzic E; Lucchi NW; Ngasala B; Kabanywanyi AM; Mahende MK; Kamugisha E; Kavishe RA; Muro F; Mohamed A; Mandike R; Mkude S; Chacky F; Paxton L; Greer G; Kitojo CA; Njau R; Martin T; Venkatesan M; Warsame M; Halsey ES; Udhayakumar V
Malar J; 2019 Mar; 18(1):88. PubMed ID: 30898164
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya.
Musyoka KB; Kiiru JN; Aluvaala E; Omondi P; Chege WK; Judah T; Kiboi D; Nganga JK; Kimani FT
Infect Genet Evol; 2020 Mar; 78():104121. PubMed ID: 31756512
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
[TBL] [Abstract][Full Text] [Related]
10. Molecular Surveillance of Artemisinin-Based Combination Therapies Resistance in Plasmodium falciparum Parasites from Bioko Island, Equatorial Guinea.
Liu Y; Liang X; Li J; Chen J; Huang H; Zheng Y; He J; Ehapo CS; Eyi UM; Yang P; Lin L; Chen W; Sun G; Liu X; Zha G; Wang J; Wang C; Wei H; Lin M
Microbiol Spectr; 2022 Jun; 10(3):e0041322. PubMed ID: 35670601
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019.
Khan AQ; Pernaute-Lau L; Khattak AA; Luijcx S; Aydin-Schmidt B; Hussain M; Khan TA; Mufti FU; Morris U
Malar J; 2020 Jun; 19(1):206. PubMed ID: 32513171
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.
Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Situakibanza HNT; Umesumbu SE; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
Malar J; 2021 Mar; 20(1):144. PubMed ID: 33706773
[TBL] [Abstract][Full Text] [Related]
13. Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018.
Chidimatembue A; Svigel SS; Mayor A; Aíde P; Nhama A; Nhamussua L; Nhacolo A; Bassat Q; Salvador C; Enosse S; Saifodine A; De Carvalho E; Candrinho B; Zulliger R; Goldman I; Udhayakumar V; Lucchi NW; Halsey ES; Macete E
Malar J; 2021 Oct; 20(1):398. PubMed ID: 34641867
[TBL] [Abstract][Full Text] [Related]
14. Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin-piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia.
Rahmasari FV; Asih PBS; Rozi IE; Wangsamuda S; Risandi R; Dewayanti FK; Permana DH; Syahrani L; Prameswari HD; Basri HH; Bustos MDG; Charunwatthana P; Dondorp AM; Imwong M; Syafruddin D
Malar J; 2023 Aug; 22(1):231. PubMed ID: 37553646
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial drug efficacy and resistance in malaria-endemic countries in HANMAT-PIAM_net countries of the Eastern Mediterranean Region 2016-2020: Clinical and genetic studies.
Adam M; Nahzat S; Kakar Q; Assada M; Witkowski B; Tag Eldin Elshafie A; Abuobaida D; Safi N; Khan MA; Nagi M; Mustafa SA; Kohestani K; Muhammad J; Khim N; Al-Hadi M; Elfaki TM; Habib MN; Khairy AKA; Hamid H; Uddin Z; Amer Y; Hassan AH; Elhag MS; Sediqi AW; Kakar I; Abdul-Ghani R; Amran JGH; Abdallrahim TA; Tamim MS; Aljasari A; Rasmussen C; Azkoul L; Warsame M
Trop Med Int Health; 2023 Oct; 28(10):817-829. PubMed ID: 37705047
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.
She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J
BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya.
Gachie B; Thiong'o K; Muriithi B; Chepngetich J; Onchieku N; Gathirwa J; Mwitari P; Magoma G; Kiboi D; Kimani F
Malar J; 2023 May; 22(1):158. PubMed ID: 37202779
[TBL] [Abstract][Full Text] [Related]
18. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.
Duah NO; Matrevi SA; de Souza DK; Binnah DD; Tamakloe MM; Opoku VS; Onwona CO; Narh CA; Quashie NB; Abuaku B; Duplessis C; Kronmann KC; Koram KA
Malar J; 2013 Oct; 12():377. PubMed ID: 24172030
[TBL] [Abstract][Full Text] [Related]
19. Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.
Koukouikila-Koussounda F; Jeyaraj S; Nguetse CN; Nkonganyi CN; Kokou KC; Etoka-Beka MK; Ntoumi F; Velavan TP
Malar J; 2017 Apr; 16(1):155. PubMed ID: 28420403
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.
Ljolje D; Dimbu PR; Kelley J; Goldman I; Nace D; Macaia A; Halsey ES; Ringwald P; Fortes F; Udhayakumar V; Talundzic E; Lucchi NW; Plucinski MM
Malar J; 2018 Feb; 17(1):84. PubMed ID: 29458380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
